| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |